home / stock / inmb / inmb short
Short Information | INmune Bio Inc. (NYSE:INMB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 30,706 |
Total Actual Volume | 279,094 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 1,535 |
Average Short Percentage | 11.63% |
Is there a INMB Short Squeeze or Breakout about to happen?
See the INMB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $5.00 | $5.05 | $5.30 | $4.8001 | 22,030 | 5,597 | 25.41% |
02-11-2020 | $5.15 | $4.89 | $5.20 | $4.89 | 12,979 | 102 | 0.79% |
02-10-2020 | $4.96 | $5.075 | $5.25 | $4.85 | 35,299 | 3,871 | 10.97% |
02-07-2020 | $5.05 | $4.9851 | $5.09 | $4.876 | 17,276 | 8,196 | 47.44% |
02-06-2020 | $5.39 | $5.0272 | $5.40 | $4.90 | 17,544 | 340 | 1.94% |
02-05-2020 | $4.90 | $4.90 | $5.1031 | $4.90 | 7,740 | 1,222 | 15.79% |
02-04-2020 | $4.8441 | $4.7811 | $4.9123 | $4.70 | 15,667 | 500 | 3.19% |
02-03-2020 | $4.94 | $4.75 | $4.9531 | $4.75 | 12,019 | 100 | 0.83% |
01-31-2020 | $4.8614 | $4.93 | $5.00 | $4.85 | 4,282 | 1,375 | 32.11% |
01-30-2020 | $4.80 | $4.78 | $4.80 | $4.77 | 5,549 | 404 | 7.28% |
01-27-2020 | $5.03 | $4.82 | $5.0539 | $4.70 | 6,074 | 1,100 | 18.11% |
01-23-2020 | $5.29 | $4.95 | $5.32 | $4.75 | 34,088 | 553 | 1.62% |
01-22-2020 | $5.6777 | $5.2502 | $5.6777 | $5.25 | 20,294 | 1,097 | 5.41% |
01-21-2020 | $5.58 | $5.60 | $5.6216 | $5.52 | 11,951 | 518 | 4.33% |
01-17-2020 | $5.68 | $5.66 | $5.7134 | $5.65 | 10,117 | 16 | 0.16% |
01-16-2020 | $5.6101 | $5.68 | $5.8382 | $5.57 | 13,358 | 2,600 | 19.46% |
01-15-2020 | $5.6602 | $5.55 | $5.7008 | $5.53 | 7,130 | 904 | 12.68% |
01-13-2020 | $5.5578 | $5.7058 | $5.82 | $5.4607 | 8,187 | 1,071 | 13.08% |
01-10-2020 | $5.75 | $5.775 | $5.7926 | $5.5835 | 5,824 | 270 | 4.64% |
01-09-2020 | $5.4994 | $5.7362 | $5.8531 | $5.4994 | 11,686 | 870 | 7.44% |
News, Short Squeeze, Breakout and More Instantly...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
Boca Raton, Florida, April 30, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is pleased to share an up...
Boca Raton, Florida, April 29, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, continues to advance its Nat...